These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21323689)

  • 1. Review article: remission rates achievable by current therapies for inflammatory bowel disease.
    Peyrin-Biroulet L; Lémann M
    Aliment Pharmacol Ther; 2011 Apr; 33(8):870-9. PubMed ID: 21323689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy of IBD in 2009.
    Harris A; Feller ER; Shah SA
    Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug resistance in inflammatory bowel diseases.
    Moreau J; Mas E
    Curr Opin Pharmacol; 2015 Dec; 25():56-61. PubMed ID: 26645664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General principles of medical therapy of inflammatory bowel disease.
    Friedman S
    Gastroenterol Clin North Am; 2004 Jun; 33(2):191-208, viii. PubMed ID: 15177534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of inflammatory bowel disease care.
    Sandborn WJ
    Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
    Rogler G
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1917-21. PubMed ID: 18785084
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological therapies in inflammatory bowel disease: top-down or bottom-up?
    Oldenburg B; Hommes D
    Curr Opin Gastroenterol; 2007 Jul; 23(4):395-9. PubMed ID: 17545775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of the pregnant patient with inflammatory bowel disease.
    Steinlauf AF; Present DH
    Gastroenterol Clin North Am; 2004 Jun; 33(2):361-85, xi. PubMed ID: 15177544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of inflammatory bowel disease in adults.
    Katz JA
    J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological therapies of inflammatory bowel disease.
    Bai A; Peng Z
    Immunotherapy; 2010 Sep; 2(5):727-42. PubMed ID: 20874655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease.
    Podolsky DK
    N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
    Siegmund B; Zeitz M
    Rocz Akad Med Bialymst; 2004; 49():22-30. PubMed ID: 15631310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How effective are the usual treatments for Crohn's disease?
    Bebb JR; Scott BB
    Aliment Pharmacol Ther; 2004 Jul; 20(2):151-9. PubMed ID: 15233694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crohn's disease: current treatment options.
    Akobeng AK
    Arch Dis Child; 2008 Sep; 93(9):787-92. PubMed ID: 18456695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment strategies for inflammatory bowel disease].
    Lémann M; Allez M
    Rev Prat; 2005 May; 55(9):984-92. PubMed ID: 16052969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy and nutrition therapy of a young patient with Crohn disease].
    Verkasalo M
    Duodecim; 2003; 119(7):617-24. PubMed ID: 12762201
    [No Abstract]   [Full Text] [Related]  

  • 19. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
    Lichtenstein GR; Abreu MT; Cohen R; Tremaine W;
    Gastroenterology; 2006 Mar; 130(3):935-9. PubMed ID: 16530531
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of inflammatory bowel disease.
    Katsanos KH; Papadakis KA
    Pharmacogenomics; 2014 Dec; 15(16):2049-62. PubMed ID: 25521361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.